Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Katherine I Ochsner"'
Autor:
Katherine I Ochsner, Wayne F. March
Publikováno v:
American Journal of Ophthalmology. 129:136-143
PURPOSE: Oral carbonic anhydrase inhibitors used to treat glaucoma have significant systemic side effects. Brinzolamide 1.0%, a new topical ocular carbonic anhydrase inhibitor, is effective apparently without significant systemic side effects. This s
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics. 9:333-340
Corneal transparency is maintained by an active transport system, located at the endothelial cell membranes. This bicarbonate-dependent pump counteracts the tendency of the corneal stroma to absorb water, swell and become opaque. Carbonic anhydrase i
Autor:
Mark J. Weiss, Stephen E. Smith, Harvey Dubiner, Katherine I. Ochsner, Thomas R Walters, Ronald L. Gross, James H. Peace
Publikováno v:
Journal of glaucoma. 17(3)
Purpose To compare the duration of action of travoprost ophthalmic solution 0.004% (Travatan Z) formulated without benzalkonium chloride (BAK) to travoprost ophthalmic solution 0.004% formulated with BAK (Travatan). Methods This was a prospective, ra
Publikováno v:
Ophthalmology. 97:1678-1683
Tryptase, a neutral endoprotease, is secreted by activated mast cells in human tissues. Tryptase levels in various body fluids have been used as an indicator of mast cell activation. The authors determined tryptase levels in unstimulated tears collec
Autor:
Marlene R. Moster, Charles F. Bosworth, Jess T. Whitson, David T. Wells, Katherine I. Ochsner, Jaime E. Dickerson, Theresa A. Landry, Michael V.W. Bergamini, John E. James, Lewis H. Silver, Russell M. Andrew, E. Kenneth Sullivan
Publikováno v:
Ophthalmology. 113(8)
Purpose The safety and intraocular pressure (IOP)-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1 were evaluated and compared with brimonidine tartrate 0.15% preserved with chlorine dioxide in patients with open-angle
Publikováno v:
Diabetes technologytherapeutics. 2(1)
Ocular spectroscopy, which is the use of the eye to monitor optically the concentration of metabolites in the body, has been successfully applied to monitor aqueous humor glucose concentration. In the United States, 1.7 million intraocular lenses are